Free shipping on all orders over $ 500

CAY10526 

Cat. No. M30939

All AbMole products are for research use only, cannot be used for human consumption.

CAY10526  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

CAY10526 is a specific microsomal PGE2 synthase-1 (mPGES1) inhibitor. CAY10526 inhibits PGE2 production through the selective modulation of mPGES1 expression but does not affect COX-2. CAY10526 significantly suppresses tumor growth and increases apoptosis in melanoma xenografts. CAY10526 reduces BCL-2 and BCL-XL (anti-apoptotic) protein levels and increases BAX and BAK (pro-apoptotic) as well as cleaved caspase 3 levels. CAY10526 inhibits cell viability (IC50<5 μM) in three melanoma cell lines expressing mPGES1.

Chemical Information
Molecular Weight 311.15
Formula C12H7BrO3S
CAS Number 938069-71-7
Form Solid
Solubility (25°C) DMSO 66.67 mg/mL (ultrasonic and warming and heat to 60°C)
Storage 4°C, protect from light, dry, sealed
References

[1] Yiqing Li, et al. Transl Cancer Res. Growth of T-cell lymphoma cells is inhibited by mPGES-1/PGE2 suppression via JAK/STAT, TGF-β/Smad3 and PI3K/AKT signal pathways

[2] Simone Di Micco, et al. Front Chem. Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition

[3] Lenisa Dandara Dos Santos, et al. Antiinflamm Antiallergy Agents Med Chem. Triazol-phenyl Antipyretic Derivatives Inhibit mPGES-1 mRNA Levels in LPS-Induced RAW 264.7 Macrophage Cells

[4] Sun-Hee Kim, et al. Pigment Cell Melanoma Res. Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression

[5] Jurairat Jongthawin, et al. Tumour Biol. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression

Related PGE synthase Products
Vipoglanstat

Vipoglanstat (BI 1029539) is an inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1; IC50 = ≤0.5 nM in isolated human whole blood). Vipoglanstat reduces LPS-induced increases in the influx of neutrophils and levels of cytokines in bronchoalveolar lavage fluid (BALF), as well as the expression of PTGES, the gene encoding mPGES-1, Cox2, and Icam1 in the lung parenchyma, in a human PTGES knock-in mouse model of acute lung injury when administered at a dose of 30 mg/kg.

mPGES1-IN-7 

mPGES-1-IN-2 is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %).

(E)-KME-4

(E)-KME-4 is a potent inhibitor of prostaglandin synthetase (PGS) with an IC50 of 0.28 μM; also inhibits 5-lipoxygenase with an IC50 of 1.05 μM.

Friluglanstat

Friluglanstat is a prostaglandin E synthase (mPGES-1) inhibitor, with anti-inflammatory activity.

UT-11

UT-11 is a potent and brain-permeable microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: CAY10526  supplier, PGE synthase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.